Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share

Go back to Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share

Quest Diagnostics (DGX) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 Guidance

February 10, 2026 6:48 AM EST

(Updated - February 10, 2026 6:49 AM EST)

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $2.42, $0.06 better than the analyst estimate of $2.36. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.75 billion.

GUIDANCE:

Quest Diagnostics sees FY2026 EPS of... More